BusinessNatco Pharma Raises Investment in US Firm eGenesis to $16.7 Million
Natco Pharma Ltd announced it will increase its investment in US biotechnology company eGenesis Inc from $14 million to $16.7 million (about ₹139 crore). Natco Pharma (Canada) Inc will invest $13.7 million and Natco Pharma USA LLC $3 million. The deal involves convertible promissory notes with 8% annual interest, expected to complete by October 31. Total investment will reach $24.7 million, supporting new therapeutic programs.
Business Standard·3h ago



